Acute Urticaria

1. Bernstein, J.A., et al., The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol, 2014. 133(5): p. 1270-7.

2. Kaplan, A.P., Clinical practice. Chronic urticaria and angioedema. N Engl J Med, 2002. 346(3): p. 175-9.

3. Schaefer, P., Acute and Chronic Urticaria: Evaluation and Treatment. Am Fam

Physician, 2017. 95(11): p. 717-724.

4. Zuberbier, T., et al., The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy, 2022. 77(3): p. 734-766.

5. Kolkhir, P., et al., Urticaria. Nat Rev Dis Primers, 2022. 8(1): p. 61.

6. Babbel, J., Ramos, C., Wangberg, H., Luskin, K., Simon, R., Adverse reactions to food additives. Journal of Food Allergy, 2021. 1: p. 8-23.

7. von Mayenburg, J. and J. Rakoski, Contact urticaria to diethyltoluamide. Contact Dermatitis, 1983. 9(2): p. 171.

8. Gimenez-Arnau, A.M., D. Pesque, and H.I. Maibach, Contact Urticaria Syndrome: a Comprehensive Review. Curr Dermatol Rep, 2022. 11(4): p. 194-201.

9. Tan, S.W., Y.C. Tam, and S.M. Pang, Cutaneous reactions to COVID-19 vaccines: A review. JAAD Int, 2022. 7: p. 178-186.

10. Sackesen, C., et al., The etiology of different forms of urticaria in childhood. PediatrDermatol, 2004. 21(2): p. 102-8.

11. Imbalzano, E., et al., Association between urticaria and virus infections: A systematic review. Allergy Asthma Proc, 2016. 37(1): p. 18-22.

12. Adelino, R., J.F. Andres-Cordon, and C. Aracelis De La Cruz Martinez, Acute urticaria with angioedema in the setting of coronavirus disease 2019. J Allergy Clin Immunol Pract, 2020. 8(7): p. 2386-2387.

13. Wu, C.C., et al., Association of acute urticaria with Mycoplasmapneumoniae infection in hospitalized children. Ann Allergy Asthma Immunol, 2009. 103(2): p. 134-9.

14. Sijapati, N., et al., Exercise-Induced Urticaria: A Rare Case Report. Cureus, 2022. 14(3): p. e23062.

15. Volcheck, G.W. and J.T. Li, Exercise-induced urticaria and anaphylaxis. Mayo Clin

Proc, 1997. 72(2): p. 140-7.

16. Kulthanan, K., et al., Food-dependent cold urticaria: A new variant of physical urticaria. J Allergy Clin Immunol Pract, 2018. 6(4): p. 1400-1402.

17. Hennino, A., et al., Pathophysiology of urticaria. Clin Rev Allergy Immunol, 2006.

30(1): p. 3-11.18. Oettgen, H.C., Mast cells in food allergy: Inducing immediate reactions and shaping long-term immunity. J Allergy Clin Immunol, 2023. 151(1): p. 21-25.

19. Sanchez-Borges, M., A. Capriles-Hulett, and F. Caballero-Fonseca, NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol, 2002. 3(9): p. 599-607.

20. Kaieda, S., et al., Interleukin-33 primes mast cells for activation by IgG immune complexes. PLoS One, 2012. 7(10): p. e47252.

21. Diaz, V.L., et al., Cold Urticaria Syndromes: Diagnosis and Management. J Allergy Clin Immunol Pract, 2023. 11(8): p. 2275-2285.22. Grattan, C.E., et al., Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol, 2007. 157(6): p. 1116-23.

23. Sabroe, R.A., et al., British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021. Br J Dermatol, 2022. 186(3): p. 398-413.

24. Kalivas, J., et al., Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol, 1990. 86(6 Pt 2): p. 1014-8.

25. Kallen, B., Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med, 2002. 11(3): p. 146-52.

26. Trautmann, A., D. Anders, and J. Stoevesandt, H(1)-Antihistamine Premedication in NSAID-Associated Urticaria. J Allergy Clin Immunol Pract, 2016. 4(6): p. 1205-1212.

27. Banerji, A., et al., Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record. J Allergy Clin Immunol Pract, 2017. 5(3): p. 744-749.

28. Toh, S., et al., Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med, 2012. 172(20): p.1582-9.

29. Rasmussen, E.R., et al., Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study. J Intern Med, 2019. 285(5): p. 553-561.

30. Haymore, B.R., et al., Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol, 2008. 101(5): p. 495-9.

31. Byrd, J.S., et al., DPP-4 inhibitors and angioedema: a cause for concern? Ann Allergy Asthma Immunol, 2011. 106(5): p. 436-8.

32. McMurray, J.J., et al., Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail, 2013. 15(9): p. 1062-73.

33. Luskin, K.T., A.A. White, and J.J. Lyons, The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia. J Allergy Clin Immunol Pract, 2021. 9(6): p. 2235-2242.